Trials / Conditions / HER 2 Low-expressing Breast Cancer
HER 2 Low-expressing Breast Cancer
4 registered clinical trials studyying HER 2 Low-expressing Breast Cancer — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy NCT06828588 | Vanderbilt-Ingram Cancer Center | EARLY_Phase 1 |
| Not Yet Recruiting | Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an A NCT07151586 | UNICANCER | Phase 2 |
| Not Yet Recruiting | PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer NCT07130344 | Centre Paul Strauss | N/A |
| Not Yet Recruiting | Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer NCT06492447 | Tianjin Medical University Cancer Institute and Hospital | — |